{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:41:25Z","timestamp":1740163285469,"version":"3.37.3"},"reference-count":16,"publisher":"BMJ","issue":"e3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2022,6,13]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>We report an 80-year-old woman who developed severe hypophosphataemia and elevated urinary phosphate levels while started on valproic acid. This occurred within 1\u20132 days of starting valproic acid. There are rare single-patient reports of the association of valproic acid with adult Fanconi syndrome. This generally occurs after long-term exposure to valproate. This is the first reported experience of Fanconi\u2019s syndrome in an adult with acute exposure to valproic acid. Clinicians should be aware of the possible association.<\/jats:p>","DOI":"10.1136\/spcare-2022-003750","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T20:09:56Z","timestamp":1656446996000},"page":"e942-e944","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Valproic acid as an adjuvant analgesic: adult Fanconi syndrome"],"prefix":"10.1136","volume":"13","author":[{"given":"Anita","family":"Maybach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Baro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaylee","family":"Kachurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7903-3993","authenticated-orcid":false,"given":"Mellar P","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"2024121022580603000_13.e3.e942.1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu377"},{"key":"2024121022580603000_13.e3.e942.2","unstructured":"Keefe P , Bokhari SRA . Fanconi syndrome. Treasure Island (FL: StatPearls, 2022."},{"key":"2024121022580603000_13.e3.e942.3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pediatrneurol.2022.03.001","article-title":"Fanconi syndrome secondary to sodium valproate therapy: experience and literature review","volume":"130","author":"Sturla \u00c1lvarez","year":"2022","journal-title":"Pediatr Neurol"},{"key":"2024121022580603000_13.e3.e942.4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s10157-017-1472-z","article-title":"Risk factors for sodium valproate-induced renal tubular dysfunction","volume":"22","author":"Koga","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"2024121022580603000_13.e3.e942.5","article-title":"Sodium valproate-induced Fanconi type proximal renal tubular acidosis","volume":"2016","author":"Knights","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2024121022580603000_13.e3.e942.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2009.12.003"},{"key":"2024121022580603000_13.e3.e942.7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.0013-9580.2005.t01-1-64204_2.x","article-title":"Valproate-Induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population","volume":"46","author":"Jaffe","year":"2005","journal-title":"Epilepsia"},{"key":"2024121022580603000_13.e3.e942.8","first-page":"363","article-title":"[Correlation between renal tubular dysfunction and serum carnitine deficiency in cases with valproate therapy]","volume":"41","author":"Ono","year":"2009","journal-title":"No To Hattatsu"},{"key":"2024121022580603000_13.e3.e942.9","first-page":"226","article-title":"[A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy]","volume":"39","author":"Ono","year":"2007","journal-title":"No To Hattatsu"},{"key":"2024121022580603000_13.e3.e942.10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s11606-011-1708-7","article-title":"Valproate-Induced Fanconi syndrome in a 27-year-old woman","volume":"26","author":"Patel","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2024121022580603000_13.e3.e942.11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs493"},{"key":"2024121022580603000_13.e3.e942.12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.23876\/j.krcp.19.056","article-title":"Proximal renal tubular acidosis with and without Fanconi syndrome","volume":"38","author":"Kashoor","year":"2019","journal-title":"Kidney Res Clin Pract"},{"key":"2024121022580603000_13.e3.e942.13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40360-016-0100-y","article-title":"Distal renal tubular acidosis without renal impairment after use of tenofovir: a case report","volume":"17","author":"Iwata","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"2024121022580603000_13.e3.e942.14","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1097\/MJT.0000000000000095","article-title":"Fanconi syndrome and antiretrovirals: it is never too late","volume":"23","author":"Luni","year":"2016","journal-title":"Am J Ther"},{"key":"2024121022580603000_13.e3.e942.15","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M120"},{"key":"2024121022580603000_13.e3.e942.16","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneph0076"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2022-003750","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:17:43Z","timestamp":1733901463000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2022-003750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":16,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2022-003750"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2022-003750","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2022,6,28]]}}}